Location: Home
  • search
  • go
  • Relate News
  • 10/4/2023Sales Expenses of 489 Chinese Pharma Cos Exceed CNY 170B in H1/2023
  • 9/26/2023AstraZeneca Looks To China For Growth - But CEO Says Spinoff Not Happe...
  • 9/24/2023Strategies for Asian Business Navigating a New Era (McKinsey)
  • 9/20/2023A Share-Listed Chinese MedPharm Cos Report Broadly Positive Performanc...
  • 9/17/2023In China's Changing Economy, MNCs Must Rethink the Mantra of Going Big...
  • 9/15/2023U.S. and Other Foreign Venture Firms Pull Back From China's Biotech Se...
  • 9/13/2023Are China's Healthcare and Biopharma Sectors Really Open for Investmen...
  • 8/30/2023Review of Rising Sales Expenditures Trend of A and H Share-Listed Chin...
  • 8/25/2023IQVIA: Overall Chinese Pharma Market Growth Up 0.3% in 2022
  • 8/24/2023Review of China Performance of Leading MNCs in China H1/2023 (Updated)
  • 8/22/2023Brand-Name Drugs Feel the Squeeze in China's Generic-Heavy Market (Pod...
  • 8/14/2023China Introduces New Policy to Boost Foreign Investment, Highlighting ...
  • 8/1/2023Compliance With China's Drug Marketing Authorization Holder Local Agen...
  • 7/31/2023AstraZeneca reports 7% Chinese Sales Growth in Q2/2023 and Upgrades FY...
  • 7/27/2023Roche Reports Strong Base Business Growth in H1, Drug Sales in China R...
  • 7/26/2023When Multinationals Start De-risking, How Will Beijing Know? (Rhodium ...
  • 7/24/2023Big Pharma Bets Big on China (WSJ)
  • 7/20/2023Sanofi Remains Bullish on China's Prospects with Plans to Launch More ...
  • 7/14/2023Bayer to Launch More Innovative Drugs in China
  • 7/5/2023Moderna Set to Make First Investment of $1B in China: Sources
  • 7/5/2023China Offers An Olive Branch to Frustrated MNC Pharma Firms: Reuters
  • 7/5/2023SMEI Forecasts Growth of Ex-Hospital and Innovative Drug Sales Before ...
  • 7/3/2023Innovative Drug Market Share on the Rise Continuously in Recent Years:...
  • 6/26/2023PODCAST: European Businesses Glum on China, and AstraZeneca Weighs Spi...
  • 6/20/2023AstraZeneca's China Head Dismisses Reports of Potential Spinoff as 'Ru...
  • 6/18/2023AstraZeneca Considers Spinning Off of Its China Business: FT
  • 6/15/2023German Businesses Faced Reality Check in China
  • 6/15/2023Swiss Companies Find Renewed Confidence in China's Post-COVID Era
  • 6/15/2023Top Ten Listed Chinese Pharma Companies by R&D Spending in 2021/2022
  • 6/5/2023AstraZeneca Defies Geopolitics to Bet on China (FT)
  • Page:3/35 Total number of articles:1050: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group